Interferon-γ increases sensitivity to chemotherapy and provides immunotherapy targets in models of metastatic castration-resistant prostate cancer
出版年份 2022 全文链接
标题
Interferon-γ increases sensitivity to chemotherapy and provides immunotherapy targets in models of metastatic castration-resistant prostate cancer
作者
关键词
-
出版物
Scientific Reports
Volume 12, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-04-22
DOI
10.1038/s41598-022-10724-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- N-cadherin inhibitor creates a microenvironment that protect TILs from immune checkpoints and Treg cells
- (2021) Yi Sun et al. Journal for ImmunoTherapy of Cancer
- Prostate cancer liver metastasis: Dormancy and resistance to therapy
- (2020) Bo Ma et al. SEMINARS IN CANCER BIOLOGY
- The unique immune microenvironment of liver metastases: Challenges and opportunities
- (2020) Aaron T. Ciner et al. SEMINARS IN CANCER BIOLOGY
- A Perspective on Therapeutic Pan-Resistance in Metastatic Cancer
- (2020) Dimitrios Korentzelos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy
- (2019) Heng-Huan Lee et al. CANCER CELL
- Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial
- (2019) Shihong Zhang et al. Cancer Immunology Research
- Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
- (2019) Emmanuel S. Antonarakis et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study
- (2018) A R Hansen et al. ANNALS OF ONCOLOGY
- Immune Checkpoint-Mediated Interactions Between Cancer and Immune Cells in Prostate Adenocarcinoma and Melanoma
- (2018) Angela Rita Elia et al. Frontiers in Immunology
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification of essential genes for cancer immunotherapy
- (2017) Shashank J. Patel et al. NATURE
- In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
- (2017) Robert T. Manguso et al. NATURE
- Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer
- (2017) Christian D. Fankhauser et al. Oncotarget
- Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy
- (2016) Xiaohong Wang et al. CANCER RESEARCH
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
- (2016) Jianjun Gao et al. CELL
- Dual Faces of IFN in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity
- (2016) M. Mandai et al. CLINICAL CANCER RESEARCH
- Liver protects metastatic prostate cancer from induced death by activating E-cadherin signaling
- (2016) Bo Ma et al. HEPATOLOGY
- Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
- (2016) Daniel Sanghoon Shin et al. Cancer Discovery
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- Disabling of the erbB Pathway Followed by IFN-γ Modifies Phenotype and Enhances Genotoxic Eradication of Breast Tumors
- (2015) Yasuhiro Nagai et al. Cell Reports
- The Mitogen-activated Protein (MAP) Kinases p38 and Extracellular Signal-regulated Kinase (ERK) Are Involved in Hepatocyte-mediated Phenotypic Switching in Prostate Cancer Cells
- (2014) Bo Ma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The spleen contributes to stroke induced neurodegeneration through interferon gamma signaling
- (2012) Hilary A. Seifert et al. METABOLIC BRAIN DISEASE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduced Surface Expression of Epithelial E-Cadherin Evoked by Interferon-Gamma Is Fyn Kinase-Dependent
- (2012) David Smyth et al. PLoS One
- Hepatocyte induced re-expression of E-cadherin in breast and prostate cancer cells increases chemoresistance
- (2011) Yvonne Chao et al. CLINICAL & EXPERIMENTAL METASTASIS
- IFN-γ-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer
- (2010) Matteo Martini et al. VACCINE
- Molecular Mechanisms of IFN-γ to Up-Regulate MHC Class I Antigen Processing and Presentation
- (2009) Fang Zhou INTERNATIONAL REVIEWS OF IMMUNOLOGY
- E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas
- (2008) Alan Wells et al. CLINICAL & EXPERIMENTAL METASTASIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started